on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Updates on Stakes in Mural Oncology
The Vanguard Group, Inc. has filed a disclosure under Rule 8.3 of the Irish Takeover Panel Act regarding its interests in Mural Oncology plc. As of August 7, 2025, Vanguard holds 772,403 ordinary shares, representing 4.47% of Mural Oncology's relevant securities. Details of the securities dealings reveal a purchase of 80 shares and a sale of 16 shares, each at a price of 1.68 USD.
The filing indicates no involvement in cash-settled or stock-settled derivatives and confirms no additional agreements or inducements related to dealing in relevant securities. No new securities transactions or derivative arrangements affecting voting rights have been reported. This submission forms part of regulatory requirements for transparency in securities dealings related to takeover activities in Ireland.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news